← Back to All Filings

Astera Labs Director Sells ~$900K Stock (10b5-1 Plan)

Low SignificanceMarch 9, 2026 at 5:47:43 PM EDT

Astera Labs, Inc.

$ALAB4CIK: 0001736297

Subscribe to track ALAB

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Astera Labs Director Sells ~$900K Stock (10b5-1 Plan)

Company: Astera Labs, Inc. (ALAB) Form: 4 | Filed: 2026-03-09 Significance: Low

Insider: Jack R. Lazar Relationship: Director

Transaction: • Type: Sale (Open Market) • Shares: 7,500 • Avg Price: ~$119.80 • Value: ~$898,472 • Owned After: 87,351

Key Insight: Director Jack Lazar sold approximately 7.9% of his direct holdings. The sale was executed automatically under a Rule 10b5-1 trading plan adopted in December 2025.

Market Context: The transaction represents a negligible fraction (<0.01%) of the company's $20.29B market cap and is not indicative of immediate sentiment shifts.

View Full Filing

Comprehensive Analysis

SEC Filing Analysis: Astera Labs, Inc. (ALAB)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: Director executes a pre-planned (10b5-1) sale of ~$900K, representing a small portion of holdings and negligible market impact.
  • Market Impact: Neutral

Company Information

FieldValue
CompanyAstera Labs, Inc.
Ticker SymbolALAB
CIK0001736297
IndustrySemiconductors & Related Devices

Insider Information

FieldValue
NameJack R. Lazar
CIK0001277624
RelationshipDirector

Transaction Details

FieldValue
Form Type4
Transaction Date2026-03-05
Transaction CodeS (Sale)
Security TypeCommon Stock
Shares Involved7,500
Avg Price Per Share~$119.80
Total Value~$898,472
Shares Owned After87,351
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$898,472
% of Market Cap0.0044%
Shares Transacted7,500
% of Shares Outstanding0.0044%
Post-Transaction Ownership87,351 shares (0.05% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: For a company with a $20.29 billion market cap, a transaction of ~$900k is immaterial to the broader stock liquidity.
  • Ownership Concentration: The insider retains 87,351 shares directly. This sale represents approximately 7.9% of their pre-transaction direct holdings.
  • Transaction Significance: Both the value and share count percentages are well below the 0.1% threshold for moderate significance.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The sale was conducted under a Rule 10b5-1 plan adopted months prior (Dec 2, 2025), removing discretionary timing concerns. The volume is too low to impact price action.

Volume & Sentiment

  • Expected Volume Impact: Negligible.
  • Sentiment Indicator: Neutral. Planned director sales are routine for liquidity and diversification.

Additional Context

Transaction Notes

  • 10b5-1 Plan: The sales were automatic pursuant to a plan adopted on December 2, 2025. This indicates the sale was not based on current non-public information.
  • Execution: Shares were sold in multiple batches ranging from ~$118.15 to ~$123.50.
Topics:#ALAB#AsteraLabs#InsiderTrading#Form4#DirectorSale#StockMarket#Semiconductors#Investing

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.